Literature DB >> 18241032

Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.

Preeta K Kutty1, Stephen R Benoit, Christopher W Woods, Arlene C Sena, Susanna Naggie, Joyce Frederick, John Engemann, Sharon Evans, Brian C Pien, Shailendra N Banerjee, Jeffery Engel, L Clifford McDonald.   

Abstract

OBJECTIVE: To determine the timing of community-onset Clostridium difficile-associated disease (CDAD) relative to the patient's last healthcare facility discharge, the association of postdischarge cases with healthcare facility-onset cases, and the influence of postdischarge cases on overall rates and interhospital comparison of rates of CDAD.
DESIGN: Retrospective cohort study for the period January 1, 2005, through December 31, 2005.
SETTING: Catchment areas of 6 acute care hospitals in North Carolina.
METHODS: We reviewed medical and laboratory records to determine the date of symptom onset, the dates of hospitalization, and stool C. difficile toxin assay results for patients with CDAD who had diarrhea and positive toxin-assay results. Cases were classified as healthcare facility-onset if they were diagnosed more than 48 hours after admission. Cases were defined as community-onset if they were diagnosed in the community or within 48 hours after admission, and were also classified on the basis of the time since the last discharge: if within 4 weeks, community-onset, healthcare facility-associated (CO-HCFA); if 4-12 weeks, indeterminate exposure; and if more than 12 weeks, community-associated. Pearson's correlation coefficient was used to assess the association between monthly rates of healthcare facility-onset, healthcare facility-associated (HO-HCFA) cases and CO-HCFA cases. We performed interhospital rate comparisons using HO-HCFA cases only and using both HO-HCFA and CO-HCFA cases.
RESULTS: Of 1046 CDAD cases, 442 (42%) were HO-HCFA cases and 604 (58%) were community-onset cases. Of the 604 community-onset cases, 94 (15%) were CO-HCFA, 40 (7%) were of indeterminate exposure, and 208 (34%) community-associated. A modest correlation was found between monthly rates of HO-HCFA cases and CO-HCFA cases across the 6 hospitals (r = 0.63, P < .001). Interhospital rankings changed for 6 of 11 months if CO-HCFA cases were included.
CONCLUSIONS: A substantial proportion of community-onset cases of CDAD occur less than 4 weeks after discharge from a healthcare facility, and inclusion of CO-HCFA cases influences interhospital comparisons. Our findings support the use of a proposed definition of healthcare facility-associated CDAD that includes cases that occur within 4 weeks after discharge.

Entities:  

Mesh:

Year:  2008        PMID: 18241032     DOI: 10.1086/528813

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  18 in total

1.  Community-associated Clostridium difficile infection: experience of a veteran affairs medical center in southeastern USA.

Authors:  S Naggie; J Frederick; B C Pien; B A Miller; D T Provenzale; K C Goldberg; C W Woods
Journal:  Infection       Date:  2010-05-08       Impact factor: 3.553

2.  Spectrum of Clostridium difficile infections outside health care facilities.

Authors:  Ed J Kuijper; Jaap T van Dissel
Journal:  CMAJ       Date:  2008-10-07       Impact factor: 8.262

3.  A multicenter study of Clostridium difficile infection-related colectomy, 2000-2006.

Authors:  Amelia M Kasper; Humaa A Nyazee; Deborah S Yokoe; Jeanmarie Mayer; Julie E Mangino; Yosef M Khan; Bala Hota; Victoria J Fraser; Erik R Dubberke
Journal:  Infect Control Hosp Epidemiol       Date:  2012-03-20       Impact factor: 3.254

Review 4.  The changing epidemiology of Clostridium difficile infections.

Authors:  J Freeman; M P Bauer; S D Baines; J Corver; W N Fawley; B Goorhuis; E J Kuijper; M H Wilcox
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

5.  Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.

Authors:  Fred C Tenover; Susan Novak-Weekley; Christopher W Woods; Lance R Peterson; Thomas Davis; Paul Schreckenberger; Ferric C Fang; Andre Dascal; Dale N Gerding; Jim H Nomura; Richard V Goering; Thomas Akerlund; Alice S Weissfeld; Ellen Jo Baron; Edith Wong; Elizabeth M Marlowe; Joseph Whitmore; David H Persing
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

Review 6.  Clostridium difficile.

Authors:  Scott Curry
Journal:  Clin Lab Med       Date:  2010-03       Impact factor: 1.935

7.  Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease?

Authors:  Erik R Dubberke; Kathleen M McMullen; Jennie L Mayfield; Kimberly A Reske; Peter Georgantopoulos; David K Warren; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2009-04       Impact factor: 3.254

Review 8.  Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections.

Authors:  Lynne Vernice McFarland; Metehan Ozen; Ener Cagri Dinleyici; Shan Goh
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

9.  Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection.

Authors:  Erik R Dubberke; Anne M Butler; Bala Hota; Yosef M Khan; Julie E Mangino; Jeanmarie Mayer; Kyle J Popovich; Kurt B Stevenson; Deborah S Yokoe; L Clifford McDonald; John Jernigan; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2009-06       Impact factor: 3.254

10.  Clostridium difficile in retail meat products, USA, 2007.

Authors:  J Glenn Songer; Hien T Trinh; George E Killgore; Angela D Thompson; L Clifford McDonald; Brandi M Limbago
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.